首页 产品目录 分子砌块 按官能团 酯类 (1R,2R,2aR,3aS,3bR,5aS,7S,9aR,9bS,11aR)-5a,7-dihydroxy-9a,11a-dimethyl-1-(2-oxo-2H-pyran-5-yl)hexadecahydronaphtho[1',2':6,7]indeno[1,7a-b]oxiren-2-yl acetate

(1R,2R,2aR,3aS,3bR,5aS,7S,9aR,9bS,11aR)-5a,7-dihydroxy-9a,11a-dimethyl-1-(2-oxo-2H-pyran-5-yl)hexadecahydronaphtho[1',2':6,7]indeno[1,7a-b]oxiren-2-yl acetate

(1R,2R,2aR,3aS,3bR,5aS,7S,9aR,9bS,11aR)-5a,7-dihydroxy-9a,11a-dimethyl-1-(2-oxo-2H-pyran-5-yl)hexadecahydronaphtho[1',2':6,7]indeno[1,7a-b]oxiren-2-yl acetate

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
1mg 95% 询价
- +
5mg 95% 询价
- +
10mg 95% 询价
- +
25mg 95% 询价
- +
50mg 95% 询价
- +
100mg 95% 询价
- +
250mg 95% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

1108-68-5

英文名称

(1R,2R,2aR,3aS,3bR,5aS,7S,9aR,9bS,11aR)-5a,7-dihydroxy-9a,11a-dimethyl-1-(2-oxo-2H-pyran-5-yl)hexadecahydronaphtho[1',2':6,7]indeno[1,7a-b]oxiren-2-yl acetate

别名

cinobufotalin venom toad;Cinobufotalin std.;5BETA,20[22]-BUFADIENOLIDE-14,15BETA-EPOXY-3BETA,5ALPHA,16BETA-TRIOL 16-ACETATE;14,15-beta-epoxy-3-beta,5,16-beta-trihydroxy-22-dienolid16-5-beta-bufa-2;CINOBUFOTALIN(RG);14,15b-Epoxy-3b,5a,16b-trihydroxy-5b,20(22)-bufadienolide 16-acetate;5β,20(22)-Bufadienolide-14,15β-epoxy-3β,5α,16β-triol 16-acetate, 14,15β-Epoxy-3β,5α,16β-trihydroxy-5β,20(22)-bufadienolide 16-acetate;14,15-Epoxy-14H-cyclopenta[a]phenanthrene, bufa-20,22-dienolide deriv.

标准英文名

(1R,2R,2aR,3aS,3bR,5aS,7S,9aR,9bS,11aR)-5a,7-dihydroxy-9a,11a-dimethyl-1-(2-oxo-2H-pyran-5-yl)hexadecahydronaphtho[1',2':6,7]indeno[1,7a-b]oxiren-2-yl acetate

分子式

C26H34O7

分子量

458.55

精确分子量

458.23

SMILES

CC(=O)O[C@H]1[C@H]2O[C@]23[C@@H]2CC[C@]4(O)C[C@@H](O)CC[C@]4(C)[C@H]2CC[C@]3(C)[C@H]1C1=COC(=O)C=C1

标准SMILES

CC(=O)O[C@@H]1[C@H](C2C=CC(=O)OC=2)[C@@]2(C)CC[C@H]3[C@@H](CC[C@]4(O)C[C@@H](O)CC[C@@]43C)[C@@]32O[C@@H]31

用途

Cinobufotalin is used for the treatment of various mid-to-late-stage cancers (including lung cancer, breast cancer, cervical cancer, and digestive system tumors such as primary hepatocellular carcinoma, gastric cancer, and colon cancer), as well as chronic hepatitis B, particularly showing remarkable efficacy in chronic hepatitis B virus carriers; it exhibits antitumor activity by inhibiting DNA and RNA synthesis in cancer cells, inducing tumor cell necrosis, and modulating intracellular cAMP/cGMP levels; it enhances both humoral and cellular immunity, ameliorates chemotherapy- or radiotherapy-induced myelosuppression (e.g., leukopenia), and synergistically potentiates the antitumor effects of chemotherapeutic agents such as 5-fluorouracil (5-Fu), cyclophosphamide (CTX), methotrexate (MTX), and vincristine (VCR) while reducing their toxic side effects; it also demonstrates significant anti-hepatitis B virus (HBV) activity by inhibiting viral replication.

InChIKey

KBKUJJFDSHBPPA-ZNCGZLKOSA-N

安全信息

SureRoute逆合成路线

1.  1108-68-5 逆合成路线 1

—
—
ACIGFQ304
1108-68-5
来源: SureRoute

2.  1108-68-5 逆合成路线 2

—
—
ACIGFQ304
1108-68-5
来源: SureRoute

3.  1108-68-5 逆合成路线 3

—
—
ACIGFQ304
1108-68-5
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手